跳至主要内容
临床试验/NCT03086057
NCT03086057已完成不适用

Optimizing Pre-exposure Prophylaxis (PrEP) Uptake & Adherence Among MSW Using a 2-stage Randomization Design

Brown University2 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2017年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
111
试验地点
2
主要终点
Number of Participants With Verified Attendance at Initial Appointment at PrEP Clinic

研究概览

简要总结

"PrEPare for Work" is a two-stage randomized controlled pilot trial which utilizes a behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis (PrEP) in Male Sex Workers (MSW).

详细描述

The "PrEPare for Work" package includes two behavioral intervention components:

  1. Strengths-based case management for PrEP initiation, and
  2. Counseling and problem-solving PrEP adherence intervention that addresses individualized barriers to optimal use.

Stage 1: MSW will be equally randomized to receive either the strengths-based case management or standard of care referral to PrEP clinic.

Stage 2: Those from stage 1 who initiate PrEP , regardless of stage 1 randomization condition, will then be equally randomized to either the "PrEPare for Work" adherence intervention or standard of care comparison condition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •18 years of age or older
  • •Biological male at birth and current male gender identity
  • •Exchanged sex for money or drugs with another man in the past 3 months
  • •Report behavioral risk for HIV infection, consistent with Centers for Disease Control and Prevention guidelines for prescribing PrEP: condomless anal intercourse with at least one HIV-infected or unknown serostatus partner in the past three months
  • •HIV uninfected by antibody test* Stage 2
  • •Able to understand and speak English (for consent and counseling)
  • •Mental competency to provide voluntary informed consent
  • •Lives in the New England area
  • •Willing to initiate PrEP

排除标准

  • •Unable to provide informed consent, including as a result of severe mental illness requiring immediate treatment or mental illness limiting the ability to participate
  • •HIV Positive at baseline
  • •Infected with Hepatitis B or diagnosed with renal insufficiency (glomerular filtration rate < 50) *Stage 2
  • •History of or current medical conditions that would preclude taking Truvada for PrEP *Stage 2
  • •Currently taking Truvada for PrEP

研究组 & 干预措施

Strength Based Case Management

Experimental

Stage 1: Support, facilitate, and assist in linkage to PrEP clinic and to facilitate initiation of, and obtaining, PrEP medications.

干预措施: PrEPare for Work: Strength Based Case Management (Stage 1) (Behavioral)

PrEP adherence training and counseling

Experimental

Stage 2: Up to three adherence training and counseling intervention sessions (once per week for two to three weeks) with a clinical interventionist.

干预措施: PrEPare for Work: Adherence Training and Counseling (Stage 2) (Behavioral)

Standard of Care:Stage 1

No Intervention

Stage 1: Referral to The Miriam Hospital PrEP Clinic.

Standard of Care: Stage 2

No Intervention

Stage 2: Doctor visit every three months to assess for side effects and receive a HIV test.

结局指标

主要结局

Number of Participants With Verified Attendance at Initial Appointment at PrEP Clinic

时间窗: 2-month post Stage 1 randomization

Number of participants with attendance at initial appointment at PrEP Clinic verified using medical records

Number of Participants Who Initiated PrEP

时间窗: 2-month post Stage 1 randomization

Initial prescription from provider filled and shown to study staff

Number of Participants Reporting Optimal PrEP Adherence

时间窗: 6-months post Stage 2 randomization

Self-reporting missing 0 PrEP pills in the past week

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthew Mimiaga

ScD, MPH

Brown University

研究点 (2)

Loading locations...

相似试验